Growth hormone therapy in boy with panhypopituitarism may induce pilomatricoma recurrence: case report.
NEURO ENDOCRINOLOGY LETTERS 2008;
29:51-54. [PMID:
18283258]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 01/20/2008] [Accepted: 01/27/2008] [Indexed: 05/25/2023]
Abstract
Pilomatricoma is usually a solitary subcutaneous nodule. Recurrence of the nodule after surgical excision is very rare. Pilomatricoma occurrence in patients with growth hormone (GH) deficiency has not been reported, yet. We report a 14-year-old boy with pilomatricoma and panhypopituitarism. After GH therapy had been started, we observed two relapses of previously completely excised pilomatricoma in the same location and a new pilomatricoma formation on the chin.
Collapse